These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
233 related articles for article (PubMed ID: 26546437)
1. Coexpression of CXCR4 and MMP9 predicts lung metastasis and poor prognosis in resected osteosarcoma. Ren Z; Liang S; Yang J; Han X; Shan L; Wang B; Mu T; Zhang Y; Yang X; Xiong S; Wang G Tumour Biol; 2016 Apr; 37(4):5089-96. PubMed ID: 26546437 [TBL] [Abstract][Full Text] [Related]
2. Expression of CXCR4 and MMP-2 is associated with poor prognosis in patients with osteosarcoma. Gong C; Sun K; Xiong HH; Sneh T; Zhang J; Zhou X; Yan P; Wang JH Histol Histopathol; 2020 Aug; 35(8):863-870. PubMed ID: 32314796 [TBL] [Abstract][Full Text] [Related]
3. The metastatic behavior of osteosarcoma by gene expression and cytogenetic analyses. Salinas-Souza C; De Oliveira R; Alves MT; Garcia Filho RJ; Petrilli AS; Toledo SR Hum Pathol; 2013 Oct; 44(10):2188-98. PubMed ID: 23845465 [TBL] [Abstract][Full Text] [Related]
4. Elevated expression of CXCR4 and correlation with clinicopathological features and prognosis of non-small cell lung cancer patients: a meta-analysis. Wang H; Xie F; Hu Z; Chen L Genet Mol Res; 2015 Dec; 14(4):17893-903. PubMed ID: 26782435 [TBL] [Abstract][Full Text] [Related]
5. PLA2G16 Expression in Human Osteosarcoma Is Associated with Pulmonary Metastasis and Poor Prognosis. Liang S; Ren Z; Han X; Yang J; Shan L; Li L; Wang B; Zhang Q; Mu T; Chen K; Xiong S; Wang G PLoS One; 2015; 10(5):e0127236. PubMed ID: 25993412 [TBL] [Abstract][Full Text] [Related]
6. High expression of C-X-C chemokine receptor 4 and Notch1 is predictive of lymphovascular invasion and poor prognosis in lung adenocarcinoma. Cong Z; Wu H; Guo Z; Qin T; Xu Y; Jing H; Wang Y; Shen Y Tumour Biol; 2017 Jun; 39(6):1010428317708698. PubMed ID: 28618922 [TBL] [Abstract][Full Text] [Related]
7. High CCL5 expression is associated with osteosarcoma metastasis and poor prognosis of patients with osteosarcoma. Sun K; Gong C; Peng H; Fang H; Zhou J; Li J; Chen S; Zheng H Mol Med Rep; 2017 Nov; 16(5):6953-6957. PubMed ID: 28901496 [TBL] [Abstract][Full Text] [Related]
8. miR-21 predicts poor prognosis in patients with osteosarcoma. Ren X; Shen Y; Zheng S; Liu J; Jiang X Br J Biomed Sci; 2016 Oct; 73(4):158-162. PubMed ID: 27922432 [TBL] [Abstract][Full Text] [Related]
9. Messenger RNA expression levels of CXCR4 correlate with metastatic behavior and outcome in patients with osteosarcoma. Laverdiere C; Hoang BH; Yang R; Sowers R; Qin J; Meyers PA; Huvos AG; Healey JH; Gorlick R Clin Cancer Res; 2005 Apr; 11(7):2561-7. PubMed ID: 15814634 [TBL] [Abstract][Full Text] [Related]
10. Correlations of lysyl oxidase with MMP2/MMP9 expression and its prognostic value in non-small cell lung cancer. Liu J; Ping W; Zu Y; Sun W Int J Clin Exp Pathol; 2014; 7(9):6040-7. PubMed ID: 25337249 [TBL] [Abstract][Full Text] [Related]
11. Expression of molecular factors correlated with metastasis in small cell lung cancer and their significance. Li XX; Li RJ; Zhao LJ; Liu NB; Wang P Int J Clin Exp Pathol; 2015; 8(11):14676-84. PubMed ID: 26823791 [TBL] [Abstract][Full Text] [Related]
12. [Correlations of S100A4 and MMP9 expressions to infiltration, metastasis and prognosis of non-small cell lung cancer]. Chen XL; Wang LC; Zhang WG; Chen XY; Sun ZM Nan Fang Yi Ke Da Xue Xue Bao; 2008 Jul; 28(7):1254-8. PubMed ID: 18676277 [TBL] [Abstract][Full Text] [Related]
13. Serum microRNA-221 functions as a potential diagnostic and prognostic marker for patients with osteosarcoma. Yang Z; Zhang Y; Zhang X; Zhang M; Liu H; Zhang S; Qi B; Sun X Biomed Pharmacother; 2015 Oct; 75():153-8. PubMed ID: 26422796 [TBL] [Abstract][Full Text] [Related]
14. Tissue microRNA-126 expression level predicts outcome in human osteosarcoma. Liu W; Zhao ZY; Shi L; Yuan WD Diagn Pathol; 2015 Jul; 10():116. PubMed ID: 26194657 [TBL] [Abstract][Full Text] [Related]
15. Stromal cell derived factor-1 and CXCR4 expression in colorectal cancer promote liver metastasis. Amara S; Chaar I; Khiari M; Ounissi D; Weslati M; Boughriba R; Hmida AB; Bouraoui S Cancer Biomark; 2015; 15(6):869-79. PubMed ID: 26406413 [TBL] [Abstract][Full Text] [Related]
16. Promoter hypermethylation of the cysteine protease RECK may cause metastasis of osteosarcoma. Wang L; Ge J; Ma T; Zheng Y; Lv S; Li Y; Liu S Tumour Biol; 2015 Dec; 36(12):9511-6. PubMed ID: 26130413 [TBL] [Abstract][Full Text] [Related]
17. Role of CXCR4 and SDF1 as prognostic factors for survival and the association with clinicopathology in colorectal cancer: A systematic meta-analysis. Li YP; Pang J; Gao S; Bai PY; Wang WD; Kong P; Cui Y Tumour Biol; 2017 Jun; 39(6):1010428317706206. PubMed ID: 28621237 [TBL] [Abstract][Full Text] [Related]
18. Elevated ratio of MMP2/MMP9 activity is associated with poor response to chemotherapy in osteosarcoma. Kunz P; Sähr H; Lehner B; Fischer C; Seebach E; Fellenberg J BMC Cancer; 2016 Mar; 16():223. PubMed ID: 26979530 [TBL] [Abstract][Full Text] [Related]
19. NanoVelcro-captured CTC number concomitant with enhanced serum levels of MMP7 and MMP9 enables accurate prediction of metastasis and poor prognosis in patients with lung adenocarcinoma. Sun Y; Chen Y; Li S; Lei Y; Xu D; Jiang N; Zhang Y; Cao J; Ke Z Int J Nanomedicine; 2017; 12():6399-6412. PubMed ID: 28919743 [TBL] [Abstract][Full Text] [Related]
20. Decreased expression of long non-coding RNA MEG3 acts as a potential predictor biomarker in progression and poor prognosis of osteosarcoma. Tian ZZ; Guo XJ; Zhao YM; Fang Y Int J Clin Exp Pathol; 2015; 8(11):15138-42. PubMed ID: 26823857 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]